$2.41 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 73 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 47.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | $121,713,000 | -1.7% | 240,997 | 0.0% | 5.05% | +7.4% | |
| UNP | Buy | UNION PAC CORP | $103,860,000 | -8.5% | 533,105 | +0.2% | 4.31% | -0.0% |
| LVS | Sell | LAS VEGAS SANDS CORP | $89,821,000 | -7.9% | 2,393,951 | -17.6% | 3.73% | +0.6% |
| MSFT | Buy | MICROSOFT CORP | $89,056,000 | +38.6% | 382,380 | +52.9% | 3.70% | +51.4% |
| DIS | Buy | DISNEY WALT CO | $87,430,000 | +163.9% | 926,850 | +164.1% | 3.63% | +188.2% |
| AMZN | New | AMAZON COM INC | $82,881,000 | – | 733,460 | +100.0% | 3.44% | – |
| OTIS | OTIS WORLDWIDE CORP | $82,779,000 | -9.7% | 1,297,480 | 0.0% | 3.44% | -1.4% | |
| EL | Buy | LAUDER ESTEE COS INCcl a | $79,793,000 | +6.9% | 369,583 | +26.1% | 3.31% | +16.8% |
| RPRX | Sell | ROYALTY PHARMA PLC | $74,040,000 | -42.8% | 1,842,718 | -40.1% | 3.07% | -37.5% |
| GPN | Buy | GLOBAL PMTS INC | $71,204,000 | +124.1% | 658,992 | +129.4% | 2.96% | +144.8% |
| FB | New | META PLATFORMS INCcl a | $67,608,000 | – | 498,290 | +100.0% | 2.81% | – |
| HLT | Buy | HILTON WORLDWIDE HLDGS INC | $65,759,000 | +63.7% | 545,171 | +51.2% | 2.73% | +78.7% |
| IQV | Sell | IQVIA HLDGS INC | $64,791,000 | -23.8% | 357,685 | -8.8% | 2.69% | -16.8% |
| TPR | Sell | TAPESTRY INC | $62,004,000 | -9.6% | 2,180,922 | -3.0% | 2.58% | -1.3% |
| TTWO | New | TAKE-TWO INTERACTIVE SOFTWAR | $58,443,000 | – | 536,170 | +100.0% | 2.43% | – |
| DHR | Buy | DANAHER CORPORATION | $58,410,000 | +5.6% | 226,142 | +3.6% | 2.42% | +15.3% |
| NOW | Buy | SERVICENOW INC | $58,209,000 | +379.6% | 154,150 | +504.0% | 2.42% | +424.3% |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $58,187,000 | -11.8% | 114,725 | -5.5% | 2.42% | -3.6% |
| KURA | Buy | KURA ONCOLOGY INC | $55,502,000 | -24.6% | 4,063,128 | +1.1% | 2.30% | -17.7% |
| CP | Buy | CANADIAN PAC RY LTD | $51,793,000 | +17.0% | 776,276 | +22.4% | 2.15% | +27.7% |
| MA | Sell | MASTERCARD INCORPORATEDcl a | $51,662,000 | -21.7% | 181,691 | -13.1% | 2.14% | -14.5% |
| TMUS | Buy | T-MOBILE US INC | $49,620,000 | +370.4% | 369,828 | +371.7% | 2.06% | +413.7% |
| V | Sell | VISA INC | $48,315,000 | -24.5% | 271,968 | -16.3% | 2.01% | -17.5% |
| ABC | Buy | AMERISOURCEBERGEN CORP | $46,253,000 | +3.9% | 341,779 | +8.6% | 1.92% | +13.5% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $44,100,000 | +13.6% | 712,561 | +46.4% | 1.83% | +24.1% |
| Sell | ARCELLX INC | $42,224,000 | -5.5% | 2,249,533 | -8.9% | 1.75% | +3.2% | |
| ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $39,642,000 | -48.1% | 851,958 | -36.4% | 1.65% | -43.4% |
| SQ | Sell | BLOCK INCcl a | $36,378,000 | -12.9% | 661,540 | -2.7% | 1.51% | -4.8% |
| MCK | Buy | MCKESSON CORP | $35,635,000 | +4.2% | 104,850 | +0.0% | 1.48% | +13.8% |
| LVS | New | LAS VEGAS SANDS CORPcall | $33,393,000 | – | 890,000 | +100.0% | 1.39% | – |
| New | PROKIDNEY CORP | $28,771,000 | – | 3,193,175 | +100.0% | 1.20% | – | |
| FULC | Buy | FULCRUM THERAPEUTICS INC | $28,542,000 | +73.6% | 3,528,000 | +5.1% | 1.18% | +89.6% |
| KZR | Sell | KEZAR LIFE SCIENCES INC | $28,202,000 | -22.7% | 3,275,520 | -25.8% | 1.17% | -15.6% |
| STRO | Buy | SUTRO BIOPHARMA INC | $27,861,000 | +15.1% | 5,020,000 | +8.1% | 1.16% | +25.8% |
| COGT | Buy | COGENT BIOSCIENCES INC | $27,790,000 | +413.5% | 1,862,600 | +210.4% | 1.15% | +460.2% |
| KDNY | Sell | CHINOOK THERAPEUTICS INC | $27,327,000 | -12.4% | 1,390,000 | -22.1% | 1.14% | -4.4% |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $27,127,000 | -47.3% | 959,214 | -58.7% | 1.13% | -42.5% |
| INSM | Sell | INSMED INC | $26,511,000 | -35.3% | 1,230,800 | -40.8% | 1.10% | -29.4% |
| EYPT | Buy | EYEPOINT PHARMACEUTICALS INC | $25,578,000 | +9.5% | 3,233,597 | +8.9% | 1.06% | +19.6% |
| KALV | Sell | KALVISTA PHARMACEUTICALS INC | $24,770,000 | +30.6% | 1,707,100 | -11.5% | 1.03% | +42.7% |
| Buy | MARINUS PHARMACEUTICALS INC | $23,526,000 | +38.5% | 3,537,700 | +0.8% | 0.98% | +51.2% | |
| PRTA | New | PROTHENA CORP PLC | $19,191,000 | – | 316,531 | +100.0% | 0.80% | – |
| GFL | Sell | GFL ENVIRONMENTAL INC | $19,064,000 | -18.2% | 753,818 | -16.5% | 0.79% | -10.6% |
| MAR | Sell | MARRIOTT INTL INC NEWcl a | $18,891,000 | -52.5% | 134,800 | -53.9% | 0.78% | -48.2% |
| PNT | Sell | POINT BIOPHARMA GLOBAL INC | $18,018,000 | -12.2% | 2,330,902 | -22.7% | 0.75% | -4.2% |
| HRTX | Sell | HERON THERAPEUTICS INC | $11,846,000 | +30.6% | 2,807,000 | -13.7% | 0.49% | +42.6% |
| LLY | New | LILLY ELI & CO | $11,382,000 | – | 35,200 | +100.0% | 0.47% | – |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $11,187,000 | – | 274,200 | +100.0% | 0.46% | – |
| Sell | PEPGEN INC | $10,723,000 | -8.6% | 1,180,984 | -0.0% | 0.44% | -0.2% | |
| New | AKILI INC | $8,191,000 | – | 3,624,163 | +100.0% | 0.34% | – | |
| ALVOTECHordinary shares | $6,760,000 | -17.7% | 1,000,000 | 0.0% | 0.28% | -9.9% | ||
| New | VENTYX BIOSCIENCES INC | $6,507,000 | – | 186,400 | +100.0% | 0.27% | – | |
| MREO | Sell | MEREO BIOPHARMA GROUP PLCspon ads | $6,342,000 | -38.1% | 7,364,438 | -19.4% | 0.26% | -32.4% |
| ORIC | Buy | ORIC PHARMACEUTICALS INC | $6,088,000 | +7.6% | 1,902,643 | +50.7% | 0.25% | +17.7% |
| PHVS | Sell | PHARVARIS N V | $5,729,000 | -68.7% | 746,965 | -9.7% | 0.24% | -65.8% |
| IFRX | Sell | INFLARX NV | $5,666,000 | +19.0% | 2,146,240 | -34.7% | 0.24% | +29.8% |
| SLDB | Sell | SOLID BIOSCIENCES INC | $4,199,000 | +34.6% | 600,000 | -88.2% | 0.17% | +46.2% |
| ATAI | Buy | ATAI LIFE SCIENCES NV | $4,056,000 | -8.2% | 1,225,501 | +1.0% | 0.17% | 0.0% |
| BOLT | Buy | BOLT BIOTHERAPEUTICS INC | $3,955,000 | -13.1% | 2,672,000 | +19.8% | 0.16% | -5.2% |
| GMTX | GEMINI THERAPEUTICS INC | $3,891,000 | -2.9% | 2,372,267 | 0.0% | 0.16% | +6.6% | |
| New | THIRD HARMONIC BIO INC | $3,794,000 | – | 200,000 | +100.0% | 0.16% | – | |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL IN | $3,683,000 | -82.3% | 88,940 | -74.5% | 0.15% | -80.7% |
| MOLN | MOLECULAR PARTNERS AGads | $2,676,000 | -1.3% | 400,000 | 0.0% | 0.11% | +7.8% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $2,136,000 | +4.1% | 4,059,894 | 0.0% | 0.09% | +14.1% | |
| New | NUVALENT INC | $1,963,000 | – | 101,003 | +100.0% | 0.08% | – | |
| SIOX | SIO GENE THERAPIES INC | $1,656,000 | -22.3% | 5,914,000 | 0.0% | 0.07% | -14.8% | |
| AMAM | AMBRX BIOPHARMA INCsponsored ads | $1,611,000 | -59.2% | 1,491,832 | 0.0% | 0.07% | -55.3% | |
| OTIC | OTONOMY INC | $928,000 | -85.8% | 3,144,196 | 0.0% | 0.04% | -84.3% | |
| FLAC | FRAZIER LIFESCIENCES ACQU CO | $872,000 | +0.9% | 87,498 | 0.0% | 0.04% | +9.1% | |
| New | BIOHAVEN LTD | $388,000 | – | 61,631 | +100.0% | 0.02% | – | |
| BNTC | BENITEC BIOPHARMA INC | $286,000 | -67.9% | 769,000 | 0.0% | 0.01% | -64.7% | |
| TMPMW | TURMERIC ACQUISITION CORP*w exp 10/08/202 | $1,000 | -75.0% | 52,775 | 0.0% | 0.00% | – | |
| OPY ACQUISITION CORP I*w exp 09/22/202 | $8,000 | -55.6% | 72,605 | 0.0% | 0.00% | -100.0% | ||
| CANOWS | Exit | CANO HEALTH INC*w exp 06/03/202 | $0 | – | -378,569 | -100.0% | -0.01% | – |
| EUCR | Exit | EUCRATES BIOMEDICAL ACQU COR | $0 | – | -99,999 | -100.0% | -0.04% | – |
| Exit | IMMUNEERING CORP | $0 | – | -200,000 | -100.0% | -0.04% | – | |
| Exit | ENTRADA THERAPEUTICS INC | $0 | – | -106,000 | -100.0% | -0.05% | – | |
| Exit | OPY ACQUISITION CORP I | $0 | – | -200,000 | -100.0% | -0.08% | – | |
| BLSA | Exit | BCLS ACQUISITION CORP | $0 | – | -200,000 | -100.0% | -0.08% | – |
| TMPM | Exit | TURMERIC ACQUISITION CORPcl a | $0 | – | -200,000 | -100.0% | -0.08% | – |
| Exit | ROIVANT SCIENCES LTD | $0 | – | -681,528 | -100.0% | -0.10% | – | |
| HRMY | Exit | HARMONY BIOSCIENCES HLDGS IN | $0 | – | -58,734 | -100.0% | -0.11% | – |
| OMEG | Exit | OMEGA ALPHA SPACcl a | $0 | – | -300,000 | -100.0% | -0.11% | – |
| EBAC | Exit | EUROPEAN BIOTECH ACQUTN CORP | $0 | – | -300,000 | -100.0% | -0.11% | – |
| TERN | Exit | TERNS PHARMACEUTICALS INC | $0 | – | -1,238,800 | -100.0% | -0.12% | – |
| RACB | Exit | RESEARCH ALLIANCE CORP II | $0 | – | -500,000 | -100.0% | -0.19% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -61,631 | -100.0% | -0.34% | – |
| COP | Exit | CONOCOPHILLIPS | $0 | – | -110,798 | -100.0% | -0.38% | – |
| OXY | Exit | OCCIDENTAL PETE CORP | $0 | – | -172,642 | -100.0% | -0.39% | – |
| CVX | Exit | CHEVRON CORP NEW | $0 | – | -71,154 | -100.0% | -0.39% | – |
| CMRX | Exit | CHIMERIX INC | $0 | – | -5,271,696 | -100.0% | -0.42% | – |
| MTCH | Exit | MATCH GROUP INC NEW | $0 | – | -287,786 | -100.0% | -0.76% | – |
| CRNX | Exit | CRINETICS PHARMACEUTICALS IN | $0 | – | -1,125,112 | -100.0% | -0.80% | – |
| MNST | Exit | MONSTER BEVERAGE CORP NEW | $0 | – | -249,802 | -100.0% | -0.88% | – |
| XOM | Exit | EXXON MOBIL CORP | $0 | – | -290,732 | -100.0% | -0.95% | – |
| MQ | Exit | MARQETA INC | $0 | – | -3,463,704 | -100.0% | -1.07% | – |
| RH | Exit | RH | $0 | – | -133,325 | -100.0% | -1.08% | – |
| FIS | Exit | FIDELITY NATL INFORMATION SV | $0 | – | -443,240 | -100.0% | -1.54% | – |
| VTRS | Exit | VIATRIS INC | $0 | – | -3,881,900 | -100.0% | -1.54% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -951,986 | -100.0% | -2.43% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -807,438 | -100.0% | -2.60% | – |
| HUM | Exit | HUMANA INC | $0 | – | -197,668 | -100.0% | -3.52% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ADOBE SYSTEMS INCORPORATED | 33 | Q4 2021 | 13.2% |
| CONSTELLATION BRANDS INC | 20 | Q4 2018 | 10.9% |
| AMAZON COM INC | 20 | Q3 2023 | 8.0% |
| UNITEDHEALTH GROUP INC | 20 | Q3 2023 | 5.7% |
| IQVIA HLDGS INC | 19 | Q3 2023 | 7.3% |
| RESTAURANT BRANDS INTL INC | 18 | Q3 2019 | 8.9% |
| UNION PAC CORP | 17 | Q2 2023 | 5.1% |
| META PLATFORMS INC | 16 | Q3 2023 | 10.9% |
| COPART INC | 15 | Q4 2021 | 2.3% |
| SUTRO BIOPHARMA INC | 15 | Q3 2023 | 1.9% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Zura Bio Ltd | June 15, 2023 | 2,850,000 | 6.6% |
| InflaRx N.V. | April 24, 2023 | 5,733,910 | 10.3% |
| Benitec Biopharma Inc. | April 18, 2023 | 3,020,214 | 10.0% |
| Aeglea BioTherapeutics, Inc. | February 13, 2023 | 6,376,373 | 10.0% |
| Bolt Biotherapeutics, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| Cano Health, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| CHIMERIX INCSold out | February 13, 2023 | 0 | 0.0% |
| Disc Medicine, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| OTONOMY, INC.Sold out | February 13, 2023 | 0 | 0.0% |
| Sio Gene Therapies Inc.Sold out | February 13, 2023 | 0 | 0.0% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.